ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for monitor Customisable watchlists with full streaming quotes from leading exchanges, such as LSE, NASDAQ, NYSE, AMEX, Bovespa, BIT and more.

EXO Exova Grp

238.50
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Exova Grp LSE:EXO London Ordinary Share GB00BKY7HG11 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 238.50 239.00 239.75 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Exova Group PLC Director/PDMR Shareholding (2037F)

22/04/2014 9:30am

UK Regulatory


Exova (LSE:EXO)
Historical Stock Chart


From Jul 2019 to Jul 2024

Click Here for more Exova Charts.

TIDMEXO

RNS Number : 2037F

Exova Group PLC

22 April 2014

EXOVA GROUP PLC

Notification of transactions of Directors and PDMRs

22 April 2014

On 17 April 2014, awards in the form of nil cost awards ("Awards") taking the form of a nil cost option or conditional award (as set out below) to acquire ordinary shares of 1 pence each ("Shares") in Exova Group plc (the "Company") were granted to certain persons discharging managerial responsibilities ("PDMRs") under the Exova Group plc Long Term Incentive Plan ("LTIP"), as set out in column 3 in the table below.

The number of Shares subject to the Awards has been determined by reference to the market value of a Share on 16 April 2014 (220 pence per Share). In addition, the Company has granted market value options under the company share option plan section of the LTIP ("CSOP options") over the number of Shares set out in column 4 of the table. The exercise price of each CSOP option is 220 pence per Share, and has also been determined by reference to the market value of a Share on 16 April 2014. The number of Shares that is capable of exercise under each nil cost option will be reduced by such number of Shares as has a market value (at the date of exercise of the CSOP option) equal to the gain made on the exercise of the CSOP option. Overall, the participant's pre-tax economic gain from the nil cost option is the same as if the CSOP option was not in place.

 
     1. Name          2. Status       3. Number        4. Number of 
                                       of Shares        Shares under 
                                       under Nil        CSOP Option 
                                      Cost Option    (where applicable) 
-----------------  ---------------  -------------  -------------------- 
 Ian El-Mokadem     Director/PDMR         306,818                13,636 
-----------------  ---------------  -------------  -------------------- 
 Anne Thorburn      Director/PDMR         131,818                13,636 
-----------------  ---------------  -------------  -------------------- 
 Hicham Abdallah    PDMR                   87,544                   N/A 
-----------------  ---------------  -------------  -------------------- 
 Hans Aberg         PDMR                   64,234                   N/A 
-----------------  ---------------  -------------  -------------------- 
 Ravijit            PDMR                  93,875*                   N/A 
  Paintal 
-----------------  ---------------  -------------  -------------------- 
 Mike Pooley        PDMR                   92,454                13,636 
-----------------  ---------------  -------------  -------------------- 
 John Willox        PDMR                   72,727                13,636 
=================  ===============  =============  ==================== 
 

* Award granted in form of a conditional share award

The vesting of the Awards and CSOP options is subject to the satisfaction of a performance condition set by the Remuneration Committee of the Company. The Awards and CSOP options will normally vest and become exercisable on the later of the third anniversary of grant and the assessment of the performance condition, subject to continued employment. A total amount of GBP1 is payable on the exercise of any nil cost option.

In addition, a nil cost option was granted as follows on 17 April 2014:

 
    1. Name         2. Status        3. Number of 
                                     Shares under 
                                    Nil Cost Option 
---------------  ---------------  ----------------- 
 Anne Thorburn    Director/PDMR             372,727 
===============  ===============  ================= 
 

As set out in the Company's Prospectus dated 11 April 2014, the vesting of this nil cost option is not subject to satisfaction of a performance condition, and is fully vested at grant. This nil cost option has been granted in recognition of Anne Thorburn's contribution to the business in the lead-up to Admission. A total amount of GBP1 is payable on the exercise of this nil cost option.

No consideration was paid for the grant of any of the above awards.

This notification is made in accordance with DTR 3.1.4

For and on behalf of Exova Group plc

Date: 22 April 2014

Neil MacLennan

Company Secretary

Telephone: 0131 333 8053

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUUAWRSAASURR

1 Year Exova Chart

1 Year Exova Chart

1 Month Exova Chart

1 Month Exova Chart